Platinum-Triggered Bond-Cleavage of Pentynoyl Amide and


Journal

Journal of the American Chemical Society
ISSN: 1520-5126
Titre abrégé: J Am Chem Soc
Pays: United States
ID NLM: 7503056

Informations de publication

Date de publication:
17 06 2020
Historique:
pubmed: 28 5 2020
medline: 14 4 2021
entrez: 28 5 2020
Statut: ppublish

Résumé

The ability to create ways to control drug activation at specific tissues while sparing healthy tissues remains a major challenge. The administration of exogenous target-specific triggers offers the potential for traceless release of active drugs on tumor sites from antibody-drug conjugates (ADCs) and caged prodrugs. We have developed a metal-mediated bond-cleavage reaction that uses platinum complexes [K

Identifiants

pubmed: 32456416
doi: 10.1021/jacs.0c01622
pmc: PMC7304066
doi:

Substances chimiques

Amides 0
Antineoplastic Agents 0
Morphinans 0
N-propargyl 0
Platinum 49DFR088MY
Cisplatin Q20Q21Q62J

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

10869-10880

Références

Chem Rev. 2017 Jul 12;117(13):8483-8496
pubmed: 27768272
Mol Cancer Ther. 2016 May;15(5):958-70
pubmed: 26944918
Nat Commun. 2014;5:3277
pubmed: 24522696
ACS Catal. 2018 Jul 6;8(7):6055-6061
pubmed: 30018848
Chimia (Aarau). 2018 Nov 30;72(11):771-776
pubmed: 30514419
Chem Rev. 2009 Oct;109(10):4911-20
pubmed: 19711978
Angew Chem Int Ed Engl. 2017 Mar 20;56(13):3579-3584
pubmed: 28198119
Eur J Pharmacol. 2014 Oct 5;740:364-78
pubmed: 25058905
Chem Sci. 2018 Jul 17;9(37):7354-7361
pubmed: 30542538
Chem Rev. 2019 Jan 23;119(2):1058-1137
pubmed: 30640441
Chem Soc Rev. 2014 Sep 21;43(18):6511-26
pubmed: 24867400
EBioMedicine. 2020 Jan;51:102578
pubmed: 31862441
Cancer Res. 2017 Dec 15;77(24):7027-7037
pubmed: 29046337
Nat Commun. 2016 Sep 07;7:12538
pubmed: 27600651
Cancer Chemother Pharmacol. 2010 Apr;65(5):817-24
pubmed: 19662415
Chem Soc Rev. 2019 Feb 18;48(4):1077-1094
pubmed: 30724944
Cell. 2011 Mar 4;144(5):646-74
pubmed: 21376230
Chem Soc Rev. 2019 Aug 12;48(16):4361-4374
pubmed: 31294429
J Am Chem Soc. 2018 Jul 11;140(27):8410-8414
pubmed: 29927585
Cancer Chemother Pharmacol. 1990;27(1):72-5
pubmed: 2173980
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2017 Mar;9(2):
pubmed: 27094725
Int J Cancer. 2017 Apr 1;140(7):1670-1679
pubmed: 27943268
Br J Cancer. 1995 Mar;71(3):598-604
pubmed: 7880744
Angew Chem Int Ed Engl. 2006 Aug 25;45(34):5645-8
pubmed: 16856188
Bioconjug Chem. 2016 Jul 20;27(7):1697-706
pubmed: 27306828
Cancer Res. 1987 Dec 1;47(23):6297-301
pubmed: 3315183
Nat Protoc. 2019 Jan;14(1):86-99
pubmed: 30470819
Br J Clin Pharmacol. 1991 Aug;32(2):173-9
pubmed: 1931468
Nat Rev Cancer. 2020 May;20(5):263-273
pubmed: 32251397
Dalton Trans. 2016 Aug 16;45(33):12992-3004
pubmed: 27493131
Angew Chem Int Ed Engl. 2017 Oct 2;56(41):12548-12552
pubmed: 28699691
Org Lett. 2012 May 18;14(10):2520-3
pubmed: 22545702
Chem Rev. 2016 Mar 9;116(5):3436-86
pubmed: 26865551
Nat Rev Drug Discov. 2017 May;16(5):315-337
pubmed: 28303026
Sci Rep. 2015 Mar 19;5:9329
pubmed: 25788464
Cell. 2019 Jun 13;177(7):1903-1914.e14
pubmed: 31031007
Proc Natl Acad Sci U S A. 2017 Sep 26;114(39):10306-10308
pubmed: 28916734
Chem Sci. 2018 Apr 6;9(17):4185-4189
pubmed: 29780549
Angew Chem Int Ed Engl. 2017 Mar 1;56(10):2636-2639
pubmed: 28128531
Cancer Res. 1993 Jun 1;53(11):2581-6
pubmed: 8388318
Angew Chem Int Ed Engl. 2014 Sep 22;53(39):10536-40
pubmed: 25138780
Nat Commun. 2018 May 15;9(1):1913
pubmed: 29765051
Nat Chem. 2016 Feb;8(2):114-9
pubmed: 26791893
Nat Commun. 2018 May 4;9(1):1484
pubmed: 29728559
Mol Cancer Ther. 2018 Jun;17(6):1341-1351
pubmed: 29592884
Org Biomol Chem. 2015 Aug 21;13(31):8556-60
pubmed: 26175224
Nat Chem Biol. 2016 Mar;12(3):129-37
pubmed: 26881764
Cell Cycle. 2009 Feb 1;8(3):505-6
pubmed: 19176997
Nat Commun. 2017 Jul 12;8:15906
pubmed: 28699627
Nat Commun. 2016 Oct 26;7:13128
pubmed: 27782215
Chem Commun (Camb). 2010 Jan 21;46(3):454-6
pubmed: 20066323
Nat Biotechnol. 2012 Jul 10;30(7):631-7
pubmed: 22781692
Angew Chem Int Ed Engl. 2015 Nov 9;54(46):13635-8
pubmed: 26403799
Cancers (Basel). 2011 Mar 15;3(1):1351-71
pubmed: 24212665
Proc Natl Acad Sci U S A. 2017 Sep 26;114(39):E8234-E8243
pubmed: 28835536
Chem Soc Rev. 2009 Aug;38(8):2269-81
pubmed: 19623349
Nat Chem. 2011 Mar;3(3):239-43
pubmed: 21336331
J Biol Chem. 1998 Jun 12;273(24):14721-30
pubmed: 9614070
Angew Chem Int Ed Engl. 2018 Feb 19;57(8):2032-2034
pubmed: 29341367
Drug Metab Dispos. 2019 Oct;47(10):1146-1155
pubmed: 31358513
Chem Rev. 2019 Jan 23;119(2):829-869
pubmed: 30618246
Bioorg Med Chem. 2018 Jul 15;26(11):3060-3064
pubmed: 29482952
Curr Opin Chem Biol. 2015 Apr;25:48-54
pubmed: 25561021
J Am Chem Soc. 2019 Oct 30;141(43):17133-17141
pubmed: 31580665
Chem Soc Rev. 2017 Aug 14;46(16):4895-4950
pubmed: 28660957
J Med Chem. 2015 Apr 9;58(7):2895-940
pubmed: 25565044
J Am Chem Soc. 2017 Oct 4;139(39):13909-13915
pubmed: 28945369

Auteurs

Bruno L Oliveira (BL)

Department of Chemistry, University of Cambridge, Lensfield Road, Cambridge CB2 1EW, United Kingdom.
Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Avenida Professor Egas Moniz, 1649-028 Lisboa, Portugal.

Benjamin J Stenton (BJ)

Department of Chemistry, University of Cambridge, Lensfield Road, Cambridge CB2 1EW, United Kingdom.

V B Unnikrishnan (VB)

Department of Chemistry, University of Cambridge, Lensfield Road, Cambridge CB2 1EW, United Kingdom.

Cátia Rebelo de Almeida (CR)

Champalimaud Centre for the Unknown, Champalimaud Foundation, Avenida Brasilia, 1400-038 Lisboa, Portugal.

João Conde (J)

Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Avenida Professor Egas Moniz, 1649-028 Lisboa, Portugal.

Magda Negrão (M)

Champalimaud Centre for the Unknown, Champalimaud Foundation, Avenida Brasilia, 1400-038 Lisboa, Portugal.

Felipe S S Schneider (FSS)

Department of Chemistry, Federal University of Santa Catarina-UFSC, Campus Trindade, Florianópolis, Santa Catarina 88040-900, Brazil.

Carlos Cordeiro (C)

Laboratório de FT-ICR e Espectrometria de Massa Estrutural, Faculdade de Ciências da Universidade de Lisboa, Campo-Grande, 1749-016 Lisboa, Portugal.

Miguel Godinho Ferreira (MG)

Champalimaud Centre for the Unknown, Champalimaud Foundation, Avenida Brasilia, 1400-038 Lisboa, Portugal.
Institute for Research on Cancer and Aging of Nice (IRCAN), Université Côte d'Azur, UMR7284 U1081 UNS, 06107 Nice, France.

Giovanni F Caramori (GF)

Department of Chemistry, Federal University of Santa Catarina-UFSC, Campus Trindade, Florianópolis, Santa Catarina 88040-900, Brazil.

Josiel B Domingos (JB)

Department of Chemistry, Federal University of Santa Catarina-UFSC, Campus Trindade, Florianópolis, Santa Catarina 88040-900, Brazil.

Rita Fior (R)

Champalimaud Centre for the Unknown, Champalimaud Foundation, Avenida Brasilia, 1400-038 Lisboa, Portugal.

Gonçalo J L Bernardes (GJL)

Department of Chemistry, University of Cambridge, Lensfield Road, Cambridge CB2 1EW, United Kingdom.
Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Avenida Professor Egas Moniz, 1649-028 Lisboa, Portugal.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH